Philip O Katz1, Stacey Zavala. 1. Jefferson Medical College, Albert Einstein Medical Center, Philadelphia, PA, USA. pkatz19512@aol.com
Abstract
INTRODUCTION: Management of gastroesophageal reflux disease (GERD) is based on the concept that gastric contents, principally acid and pepsin, are responsible for symptoms of reflux and esophageal injury. Pharmacologic treatment is based on the principle that controlling intragastric pH will affect esophageal healing and subsequently symptom relief. RESULTS AND DISCUSSION: Control of pH can be accomplished with antisecretory agents, principally proton pump inhibitors (PPIs). The majority of patients respond to a single daily dose of a PPI; however, some will require higher doses, and a small percentage are "refractory" to twice daily dosing of these drugs. The success of these agents, and in fact the reasons for "failure," is elucidated by understanding the mechanism of action of PPIs and the effect of dose timing and meals on their efficacy. CONCLUSION: Awareness of new concerns regarding potential side effects of PPIs when used long-term require careful thought as GERD is a chronic disease with most needing some form of medical treatment over time. This article reviews the pharmacologic properties of PPIs and the impact on the treatment of GERD.
INTRODUCTION: Management of gastroesophageal reflux disease (GERD) is based on the concept that gastric contents, principally acid and pepsin, are responsible for symptoms of reflux and esophageal injury. Pharmacologic treatment is based on the principle that controlling intragastric pH will affect esophageal healing and subsequently symptom relief. RESULTS AND DISCUSSION: Control of pH can be accomplished with antisecretory agents, principally proton pump inhibitors (PPIs). The majority of patients respond to a single daily dose of a PPI; however, some will require higher doses, and a small percentage are "refractory" to twice daily dosing of these drugs. The success of these agents, and in fact the reasons for "failure," is elucidated by understanding the mechanism of action of PPIs and the effect of dose timing and meals on their efficacy. CONCLUSION: Awareness of new concerns regarding potential side effects of PPIs when used long-term require careful thought as GERD is a chronic disease with most needing some form of medical treatment over time. This article reviews the pharmacologic properties of PPIs and the impact on the treatment of GERD.
Authors: P O Katz; F K Koch; E D Ballard; R G Bagin; T C Gautille; G C Checani; D L Hogan; V S V Pratha Journal: Aliment Pharmacol Ther Date: 2007-01-15 Impact factor: 8.171
Authors: E C Klinkenberg-Knol; F Nelis; J Dent; P Snel; B Mitchell; P Prichard; D Lloyd; N Havu; M H Frame; J Romàn; A Walan Journal: Gastroenterology Date: 2000-04 Impact factor: 22.682
Authors: Donald O Castell; Peter J Kahrilas; Joel E Richter; Nimish B Vakil; David A Johnson; Seth Zuckerman; Wendy Skammer; Jeffrey G Levine Journal: Am J Gastroenterol Date: 2002-03 Impact factor: 10.864
Authors: K Bachmann; R Wachowiak; C Rempf; Y Vashist; O Mann; E F Yekebas; J R Izbicki; K A Gawad Journal: Surg Endosc Date: 2011-05-14 Impact factor: 4.584
Authors: Martin Riegler; Sebastian F Schoppman; Luigi Bonavina; David Ashton; Thomas Horbach; Matthias Kemen Journal: Surg Endosc Date: 2014-08-30 Impact factor: 4.584
Authors: Heather F Warren; Jessica L Reynolds; John C Lipham; Joerg Zehetner; Nikolai A Bildzukewicz; Paul A Taiganides; Jody Mickley; Ralph W Aye; Alexander S Farivar; Brian E Louie Journal: Surg Endosc Date: 2015-11-05 Impact factor: 4.584